MX394245B - Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. - Google Patents
Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.Info
- Publication number
- MX394245B MX394245B MX2018014080A MX2018014080A MX394245B MX 394245 B MX394245 B MX 394245B MX 2018014080 A MX2018014080 A MX 2018014080A MX 2018014080 A MX2018014080 A MX 2018014080A MX 394245 B MX394245 B MX 394245B
- Authority
- MX
- Mexico
- Prior art keywords
- fibromyalgia
- syndrome associated
- carbamate compound
- prevent
- treat
- Prior art date
Links
- 208000001640 Fibromyalgia Diseases 0.000 title abstract 6
- 208000011580 syndromic disease Diseases 0.000 title abstract 3
- -1 CARBAMATE COMPOUND Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061392 | 2016-05-19 | ||
| PCT/KR2017/005173 WO2017200318A1 (ko) | 2016-05-19 | 2017-05-18 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018014080A MX2018014080A (es) | 2019-04-04 |
| MX394245B true MX394245B (es) | 2025-03-19 |
Family
ID=60325216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018014080A MX394245B (es) | 2016-05-19 | 2017-05-18 | Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10849882B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3459543B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7071287B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102489052B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109475529B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017265839B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018073553A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3024286A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3459543T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2935596T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX394245B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3459543T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2753525C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017200318A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102635941B1 (ko) * | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| EP3711758B1 (en) | 2017-11-14 | 2024-03-27 | SK Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating or treating absence seizure or epilepsy showing absence seizure |
| KR102739580B1 (ko) * | 2017-11-14 | 2024-12-06 | 에스케이바이오팜 주식회사 | 후기 나트륨 전류의 증가와 관련된 질환을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
| ES3027977T3 (en) * | 2017-11-14 | 2025-06-17 | Sk Biopharmaceuticals Co Ltd | Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease |
| CA3116195A1 (en) * | 2018-10-19 | 2020-04-23 | Sk Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy |
| IL293096A (en) * | 2019-11-22 | 2022-07-01 | Sk Biopharmaceuticals Co Ltd | Oral pharmaceutical composition comprising carbamate compound and preparation method therefor |
| IT202300007314A1 (it) | 2023-04-14 | 2024-10-14 | Soal Pharma Srl | Integratore alimentare per il trattamento della fibromialgia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| US20030069306A1 (en) * | 2001-07-16 | 2003-04-10 | Codd Ellen C. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| US7598279B2 (en) | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| MY155662A (en) * | 2009-06-22 | 2015-11-13 | Sk Biopharmaceuticals Co Ltd | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| JP5901528B2 (ja) * | 2009-11-06 | 2016-04-13 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 線維筋痛症候群の治療方法 |
-
2017
- 2017-05-16 KR KR1020170060714A patent/KR102489052B1/ko active Active
- 2017-05-18 RU RU2018144785A patent/RU2753525C2/ru active
- 2017-05-18 AU AU2017265839A patent/AU2017265839B2/en active Active
- 2017-05-18 DK DK17799675.8T patent/DK3459543T3/da active
- 2017-05-18 US US16/302,858 patent/US10849882B2/en active Active
- 2017-05-18 ES ES17799675T patent/ES2935596T3/es active Active
- 2017-05-18 BR BR112018073553-1A patent/BR112018073553A2/pt not_active Application Discontinuation
- 2017-05-18 CN CN201780030906.XA patent/CN109475529B/zh active Active
- 2017-05-18 WO PCT/KR2017/005173 patent/WO2017200318A1/ko not_active Ceased
- 2017-05-18 PL PL17799675.8T patent/PL3459543T3/pl unknown
- 2017-05-18 MX MX2018014080A patent/MX394245B/es unknown
- 2017-05-18 EP EP17799675.8A patent/EP3459543B1/en active Active
- 2017-05-18 CA CA3024286A patent/CA3024286A1/en active Pending
- 2017-05-18 JP JP2018560460A patent/JP7071287B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018073553A2 (pt) | 2019-03-19 |
| EP3459543A1 (en) | 2019-03-27 |
| CA3024286A1 (en) | 2017-11-23 |
| RU2753525C2 (ru) | 2021-08-17 |
| EP3459543A4 (en) | 2020-01-15 |
| CN109475529A (zh) | 2019-03-15 |
| RU2018144785A3 (cg-RX-API-DMAC7.html) | 2020-08-11 |
| ES2935596T3 (es) | 2023-03-08 |
| AU2017265839A1 (en) | 2018-12-13 |
| KR102489052B1 (ko) | 2023-01-16 |
| JP2019516707A (ja) | 2019-06-20 |
| CN109475529B (zh) | 2022-02-22 |
| EP3459543B1 (en) | 2022-12-21 |
| DK3459543T3 (da) | 2023-02-13 |
| MX2018014080A (es) | 2019-04-04 |
| WO2017200318A1 (ko) | 2017-11-23 |
| KR20170131242A (ko) | 2017-11-29 |
| AU2017265839B2 (en) | 2022-10-27 |
| US10849882B2 (en) | 2020-12-01 |
| RU2018144785A (ru) | 2020-06-19 |
| PL3459543T3 (pl) | 2023-04-11 |
| US20190298694A1 (en) | 2019-10-03 |
| JP7071287B2 (ja) | 2022-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX394245B (es) | Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. | |
| ZA202202097B (en) | Amino pyrimidine ssao inhibitors | |
| CY1124652T1 (el) | Παραγωγα 1η-ινδαζολο-3-καρβοξαμιδιου και σχετικες ενωσεις ως αναστολεις παραγοντα d για τη θεραπεια νοσων που χαρακτηριζονται απο μη φυσιολογικη δραστηριοτητα συστηματος συμπληρωματος, οπως π.χ. ανοσολογικες διαταραχες | |
| SA518400356B1 (ar) | مثبطات الأرجيناز واستخداماتها العلاجية | |
| MY199409A (en) | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors | |
| BR112018070602A2 (pt) | composto, composição farmacêutica, uso do composto, e, método para tratar uma doença ou distúrbio | |
| BR112017003054A2 (pt) | compostos de aminopirimidinila como inibidores de jak | |
| MX395482B (es) | Compuestos antiproliferativos y metodos de uso de los mismos | |
| EA201891203A1 (ru) | Гетероциклические соединения в качестве иммуномодуляторов | |
| MX2016011825A (es) | Derivado de 1,3-benzodioxol. | |
| UA118149C2 (uk) | Інгібітор jak | |
| EA201792116A1 (ru) | Ингибитор янус-киназы | |
| EA201990044A1 (ru) | Гетероциклические соединения в качестве антибактериальных средств | |
| MX2019009501A (es) | Compuestos de amino piridina utiles como inhibidores de ssao. | |
| MX2021006011A (es) | Un inhibidor de la quinasa aurora a para su uso en el tratamiento del neuroblastoma. | |
| PH12019501690A1 (en) | Pyrimidine compound and pharmaceutical use thereof | |
| MX2020003593A (es) | Compuestos de benzotiazol y metodos para usar los mismos para tratar trastornos neurodegenerativos. | |
| HK1254954A1 (zh) | Lpt-723和免疫检查点抑制剂组合物及其治疗方法 | |
| JOP20190053A1 (ar) | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط | |
| MX388175B (es) | Compuestos terapéuticos y métodos para utilizarlos | |
| EA035519B9 (ru) | 1,3,4-тиадиазольные соединения и их применение в лечении рака | |
| MX2021012096A (es) | Compuestos de indenilo, composiciones farmaceuticas y usos medicos del mismo. | |
| DOP2018000134A (es) | Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cáncer | |
| EA201991688A1 (ru) | Фармацевтические комбинации для лечения рака | |
| MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. |